JOURNEY MEDICAL CORP (DERM)
US48115J1097 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 27.44M | 32.00M | 49.10M | 8.20M | |||
| Cash Equivalents | 22.46M | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 10.67M | 15.22M | 28.20M | 23.10M | 23.90M | |||
| Inventories | 11.79M | 10.21M | 14.20M | 9.90M | 1.40M | |||
| Other Current Assets | 1.24M | 3.59M | 3.30M | 2.40M | 1.70M | |||
| Total Current Assets | 46.16M | 56.45M | 77.70M | 84.50M | 35.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 32.00K | 101.00K | 200.00K | 100.00K | 200.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 17.84M | 20.29M | 27.20M | 12.60M | 15.00M | |||
| Other Non-Current Assets | 6.00K | 6.00K | 100.00K | 200.00K | 1.50M | |||
| Total Non-Current Assets | 17.88M | 20.39M | 27.50M | 12.80M | 16.70M | |||
| TOTAL ASSETS | 64.04M | 76.85M | 105.20M | 97.30M | 51.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | N/A | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.25M | 3.00M | 5.20M | 5.30M | 4.50M | |||
| Accrued Expenses | 16.37M | 20.47M | 19.60M | 22.90M | 21.60M | |||
| Accounts Payable | 15.71M | 18.34M | 37.00M | 23.40M | 2.00M | |||
| Other Current Liabilities | N/A | 53.00K | 5.00M | N/A | N/A | |||
| Total Current Liabilities | 33.33M | 41.87M | 66.80M | 51.60M | 28.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.79M | 14.62M | 21.20M | 3.60M | 13.40M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 0.00 | 9.00K | 100.00K | 0.00 | 200.00K | |||
| Total Non-Current Liabilities | 19.79M | 14.63M | 21.40M | 3.60M | 13.50M | |||
| TOTAL LIABILITIES | 53.12M | 56.50M | 88.20M | 55.20M | 41.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -88.55M | -72.36M | -68.50M | -38.90M | 5.10M | |||
| Additional Paid In Capital | 99.47M | 92.70M | 85.50M | 80.90M | 5.20M | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 20.73M | 19.32M | 17.80M | 17.30M | 16.40M | |||
| Tangible Book Value per Share | -0.33 | 0.00 | -0.57 | 1.70 | -0.29 | |||
| Total Shareholders' Equity | 10.93M | 20.35M | 17.00M | 42.00M | 10.30M | |||
| TOTAL LIABILITIES AND EQUITY | 64.04M | 76.85M | 105.20M | 97.30M | 51.90M | |||
| Statistics | ||||||||
| Debt/Equity | 1.81 | 0.72 | 1.25 | 0.09 | 1.30 | |||
| Current Ratio | 1.38 | 1.35 | 1.16 | 1.64 | 1.25 | |||
| Return On Assets (ROA) | -28.63% | -5.01% | -28.17% | -45.21% | 10.17% | |||
| Return On Equity (ROE) | -167.82% | -18.93% | -174.29% | -104.74% | 51.26% | |||
| Return On Invested Capital (ROIC) | N/A | 2.42% | N/A | N/A | 26.06% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 2.42% | N/A | N/A | 26.06% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | 5.75% | N/A | N/A | 70.47% | |||
All data in USD , ROIC based on taxRate of 0.21